Abera Bioscience AB (NGM: ABERA)
Sweden
· Delayed Price · Currency is SEK 3.930
+0.070 (1.81%)
At close: Jan 28, 2025
Abera Bioscience AB Market Cap
Abera Bioscience AB has a market cap or net worth of 60.80 million as of January 29, 2025. Its market cap has decreased by -15.43% in one year.
Market Cap
60.80M
Enterprise Value
57.69M
Revenue
12.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.93
Market Cap Chart
Since February 24, 2021, Abera Bioscience AB's market cap has decreased from 115.59M to 60.80M, a decrease of -47.40%. That is a compound annual growth rate of -15.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2025 | 60.80M | -12.20% |
| Dec 30, 2024 | 69.24M | -7.23% |
| Dec 29, 2023 | 74.63M | 20.46% |
| Dec 30, 2022 | 61.96M | -64.21% |
| Dec 30, 2021 | 173.12M | 49.77% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Investor AB | 962.32B |
| Atlas Copco AB | 855.63B |
| AB Volvo | 630.41B |
| EQT AB | 416.06B |
| ASSA ABLOY AB | 373.44B |
| Skandinaviska Enskilda Banken AB | 321.54B |
| Hexagon AB | 320.65B |
| Sandvik AB | 290.26B |